Similarly conflicting results were obtained when the proportions of circulating T-and B-lymphocytes were studied."1 '8 In view of these divergent findings, the present study was performed with the aim of investigating peripheral blood lymphocyte function in a series of Crohn's disease patients by means of a reverse haemolytic plaque. assay. We measured spontaneous immunoglobulin secreting cells, reflecting in vivo conditions, as well as pokeweed-mitogen-induced immunoglobulin secreting cells, reflecting the transforming capacity of resting B-cells. 19 To define immunoregulatory influences of T-helper and Tsuppressor cells, coculture experiments were done with isolated T-and B-cell populations obtained from normal individuals and patients with Crohn's disease. 37 
Results

SPONTANEOUS IMMUNOGLOBULIN SECRETING CELLS IN PATIENTS WITH CROHN'S DISEASE
Spontaneous immunoglobulin secreting cells were estimated immediately after cell separation using the reverse haemolytic plaque assay. As shown in Figure 1 , patients with active Crohn's disease (CDAI >150) showed a significant increase in spontaneous immunoglobulin secreting cells compared with normal individuals as well as Crohn's disease patients with inactive disease (2934 vs 313 vs 554). In patients with inactive Crohn's disease, we also found an increase in spontaneous immunoglobulin secreting cells, which was not statistically significant. In active Crohn's disease, there was no difference between patients with short term treatment and untreated patients. The most exciting finding of the present study was a marked significant increase of spontaneous immunoglobulin secreting cells in patients with active Crohn's disease (approximately 10 x normal values) and, to a lesser extent, in patients with inactive Crohn's disease (approximately 2 x normal values) (Fig. 1) . Correspondingly, there was a significant inability of peripheral blood lymphocytes from both active and inactive Crohn's disease patients to differentiate into immunoglobulin secreting cells after stimulation with pokeweedmitogen in vitro (Fig. 2) . These findings are consistent with a marked degree of polyclonal B-cell activation in vivo and agree on the whole with the results of Holdstock et a126 and Macdermott et To explain the phenomenon of polyclonal B-cell activation on a cellular basis, three abnormalities have been proposed: (1) excessive T-cell help, (2) decreased T-cell suppression, or (3) direct B-cell activation. To discriminate between these possibilities, coculture experiments were performed: unseparated, pokeweed-mitogen-stimulated lymphocytes from a normal individual and a patient with active or inactive Crohn's disease were cocultured. These pilot experiments revealed no evidence for an altered function of T-suppressor cells in Crohn's disease patients. Furthermore, in experiments with separated T-and B-cells from normal individuals and Crohn's disease patients, evidence of an intrinsic B-cell defect as well as a defective T-helper cell capacity was manifest in almost all patients. Defective helper cell capacity in Crohn's disease patients was easily demonstrable in coculture experiments between normal B-cells and patients' T-cells ( In general, our findings make the assumption of excessive T-cell help or defective T-cell suppression in Crohn's disease patients seem unlikely. This conclusion is also supported by numerous marker analyses1447 30 including the present one (Table 2 ).
Therefore we would favour the hypothesis of a direct polyclonal B-cell activation in patients with Crohn's disease, which is substantiated by the observation that the extent of polyclonal B-cell activation was not affected by short-term treatment (one to four days) in four patients with active disease. Thus, one might speculate that polyclonal activation, possibily due to an infectious agent(s), may initiate or perpetuate an autoimmune process leading to the presence of circulating antibodies to bowel epithelial cells. 39 An unresolved problem is whether the abnormal immune reactivity in the peripheral blood is relevant to the pathogenesis of the intestinal inflammatory process or only a concomitant phenomenon. As 
